| dc.contributor.author | Liang, C. | |
| dc.contributor.author | Tabak, F. | |
| dc.contributor.author | Janssen, H. L. | |
| dc.contributor.author | Qi, X. | |
| dc.contributor.author | Hansen, B. E. | |
| dc.contributor.author | Liem, S. | |
| dc.contributor.author | van Campenhout, M. J. | |
| dc.contributor.author | Chi, H. | |
| dc.contributor.author | Brouwer, W. P. | |
| dc.contributor.author | Xie, Q. | |
| dc.date.accessioned | 2021-03-05T07:59:06Z | |
| dc.date.available | 2021-03-05T07:59:06Z | |
| dc.identifier.citation | Liem S., van Campenhout M. J. , Chi H., Brouwer W. P. , Xie Q., Qi X., Liang C., Tabak F., Hansen B. E. , Janssen H. L. , "Addition of (pegylated) interferon to entecavir increases response in treatment naive HBeAg-positive patients with chronic hepatitis B", International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_96943b95-5541-457d-bfdf-15b02e98e5e0 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/101366 | |
| dc.identifier.uri | https://doi.org/10.1016/s0168-8278(17)31858-5 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.title | Addition of (pegylated) interferon to entecavir increases response in treatment naive HBeAg-positive patients with chronic hepatitis B | |
| dc.type | Bildiri | |
| dc.contributor.department | University Of Toronto , , | |
| dc.identifier.volume | 66 | |
| dc.contributor.firstauthorID | 150835 | |
